Imunoterapia: Novas Esperanças e a Busca Contínua por Aprimoramento

“In recent studies, we have identified immune cell subpopulations and soluble mediators that are increased in the blood of patients that do not respond to immunotherapy checkpoint inhibitors. With this finding, we can now study ways of inhibiting or blocking these components to favor the reactivation of an anti-tumor immune response..”